Press Releases IXICO plc

Equities

IXI

GB00BFXR4C20

Delayed London S.E. Other stock markets 05:49:21 2024-05-08 am EDT			5-day change	1st Jan Change
7.75 ^GBX	-4.62%		-4.62%	-38.00%

Apr. 15	Ixico inks supply agreement with Life Molecular Imaging for Neuraceq	AN
Apr. 15	IXICO plc Provides Information on Its Agreement with Life Molecular Imaging for the Supply of Neuraceq Amyloid PET Tracer	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

IXICO : Huntington’s Disease Image Harmonization Consortium secures new member and funding to complete large-scale analysis of brain changes using IXIQ.Ai	23-07-12	PU
IXICO : Deep-learning methods for enrichment of Alzheimer’s Disease clinical trials using MRI and PET	23-04-03	PU
IXICO : AGM 2023 – Notice	22-12-16	PU
IXICO : Application of fully automatic Hippocampal sub-field segmentation volumes to standard resolution T1 MR Imaging in Alzheimer’s disease	22-12-12	PU
ANNUAL RESULTS: ANALYST PRESENTATION	22-12-09	PU
IXICO : ANNUAL REPORT 2022	22-12-06	PU
IXICO : New consortium will use artificial intelligence technology to conduct large-scale analysis of brain changes in Huntington’s disease	22-09-21	PU
IXICO : INTERIM RESULTS ANALYST PRESENTATION	22-05-25	PU
IXICO : Contract award with a new client for a Huntington's Disease ('HD') trial worth circa £800,000	22-04-20	PU
CHDI's 17th Annual Therapeutics Conference: The Future of Huntington's Research	22-03-21	PU
GAP-Net Site Optimization Conference 2022: Event Review	22-03-08	PU
IXICO & GAP Foundation: Alzheimer’s & The Bio-Hermes Study	22-03-02	PU
IXICO : Discover IXIQ.Ai \| IXICO's AI-Based Brain Segmentation Platform	22-02-18	PU
IXICO : Hails The Introduction of IXIQ.Ai, Its New Brain Imaging Technology	22-02-18	PU
IXICO : Engagement In Big Data Research Dementia Collaboration	22-01-25	PU
IXICO : AGM 2022 – Notice	21-12-17	PU
IXICO : Interview with IXICO & GAP foundation	21-12-06	PU
ANNUAL RESULTS: ANALYST PRESENTATION	21-12-06	PU
IXICO : ANNUAL REPORT 2021	21-12-06	PU
Phase III demyelinating disorder contract award with largest Pharma client worth >£1.0m	21-11-03	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases IXICO plc

Equities

IXI

GB00BFXR4C20

Press Releases

Filters